MediSpend to acquire Alucio.

MediSpend, a life science firm, agreed to acquire Alucio, a technology company. Financial terms were not disclosed. "This acquisition brings valuable innovation into the MediSpend platform. With these added capabilities, we're strengthening our ability to support medical affairs teams with smarter tools for managing content and delivering compliant, high-quality scientific communications," Leigh Powell, MediSpend Executive Chairman.